Skip to content
Home/Companies/Biotech/Cormorant Pharmaceuticals

Cormorant Pharmaceuticals

Biotech·Sweden·Exited 2016·Held 4yr
Entry
2012
Hold
4yr
Exit
2016

Who owns Cormorant Pharmaceuticals?

Cormorant Pharmaceuticals was owned by Flerie through Flerie Invest (2011 vintage) from 2012 to 2016, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-17

Flerie
Investor
Flerie
Flerie Invest · 2011 · Life Sciences VC

Key facts

HQSweden
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
Exit Year
2016
Track Cormorant Pharmaceuticals

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Cormorant Pharmaceuticals?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Cormorant Pharmaceuticals.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue